Imprivata Mobile Device Access
Simple and secure access management for mission-critical industries
Est 2000|Valuation $492.5M|Raised $2.6B
Simple and secure access management for mission-critical industries
Published May 16, 2026
Less appropriate when:
No explicit public performance or scale benchmarks were found (for example, maximum devices per appliance or latency targets). Buyers should request reference architectures and sizing guidance.
Recurring reasons cited for selecting Imprivata include:
Sources:
Commonly cited or implied issues:
Sources:
Publicly available failed-implementation accounts are typically informal (forums, community posts) and often lack detail. These anecdotal reports indicate that pilots can encounter issues and that implementations should be validated with a clear test plan.
Source:
Source:
Decision makers:
End users:
Appropriate when an organization requires:
Primary market is healthcare and other mission-critical industries, with additional references to commercial/frontline environments.
Sources:
Get a comprehensive analysis of Imprivata Mobile Device Access including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →Sources:
Imprivata publishes feature release events and public roadmap materials. Example: a Mobile Device Access feature release event (December 10, 2025) and public roadmap PDFs.
Sources:
Sources:
Imprivata’s MDA product page includes customer quotes such as:
These are vendor-published quotations and are not independently validated in the cited page; they should be treated as promotional statements unless corroborated by third-party case studies with methodology.
Source:
MDA-specific reviews are less common than reviews for Imprivata Enterprise Access Management / OneSign. Many reviewers discuss desktop SSO/badge workflows rather than mobile shared device access.
Gartner Peer Insights (Imprivata Enterprise Access Management) includes reviews that generally praise reliability while noting deployment and upgrade effort and support variability.
G2 (Imprivata Enterprise Access Management / OneSign listing) shows a mix of praise and criticism, including comments about ease of use and complaints about support responsiveness and certain feature gaps.
Capterra and PeerSpot listings provide additional end-user sentiment and synthesized themes; these platforms represent user-submitted feedback that should be treated as directional.
Sources:
Reddit threads reference Imprivata in healthcare IT and endpoint/login workflow contexts. While not always MDA-specific, they highlight operational friction points relevant to shared devices and authentication.
Examples include reports of Android accessibility stability concerns and pilot deployments with issues. Community posts are anecdotal and require validation.
Examples:
Sources:
Sources:
Typical fit tends to be mid-market to large enterprise, especially where:
Practical ICP examples:
Sources:
Imprivata Mobile Device Access (MDA) is a mobile access and authentication product focused on shared Android devices. It extends Imprivata’s enterprise access management stack (historically OneSign / Enterprise Access Management) to mobile by enabling:
Vendor materials describe MDA as designed to balance usability (reduced password entry and faster workflows) with security and compliance for environments where devices are frequently handed off (e.g., clinical scanners/phones, rugged handhelds). Vendor marketing states it aims to increase user adoption and return on investment for shared-device programs.
Sources: